Top Story

Herantis Pharma pursues phase 2 study for dry eye treatment

September 15, 2014

The U.S. Food and Drug Administration has cleared the Investigational New Drug application of Herantis Pharma for a phase 2 clinical study of Cis-UCA eye drops for dry eye syndrome.

According to a press release from Herantis, patient enrollment is planned to begin by the end of this year.

Breaking News

Jetrea approved in South Korea for symptomatic vitreomacular adhesion

September 8, 2014
Jetrea has been approved in South Korea for the treatment of symptomatic vitreomacular adhesion, according to a ThromboGenics press release.This is the fourth country in…
Breaking News

Ozurdex approved in EU for treatment of DME

September 2, 2014
The European Commission has extended marketing authorization for Ozurdex for the treatment of diabetic macular edema in certain patients, according to an Allergan press…

California optometry scope expansion bill tabled until 2015

August 27, 2014
A bill in California that intended to allow optometrists to use therapeutic lasers and pharmaceutical agents approved by the U.S. Food and Drug Administration as well as…
More News Headlines »

'Be neither fish nor fowl'

August 13, 2014
This wise saying has roots that go back at least to the 15th century. It has been applied in many different contexts…
More »